MDA SpaceBuy the financing air pocket

A scarce, at-scale Western satellite manufacturer was marked down for deal financing while the sovereign pipeline, margin path and recurring-revenue mix improved. Start small. Add only as the evidence arrives.

RatingBuyStaged underwriting
Pitch Anchor · Jul 13 CloseUS$31.47C$44.65 · scenario framework
Post-Settlement CheckUS$33.20Jul 15 · 11:53 ET · static quote
Initial Size50–75 bpsAdd toward ~150 bps on gates
Decision RuleStart here. Add on a book-to-bill turn, ESCP-P or FY27 margin guidance above 20%. Trim/exit on backlog below C$3.5B exiting FY26 without ESCP-P, margins ≤19.5% for two prints, or another equity raise. Five-case weighted value is ~C$60 (+34% versus the July 13 C$44.65 anchor); deck base case is C$64.
Bear · 15%C$28Reload stalls
Skeptic · 20%C$42CE margins hold
Base · 35%C$64Model + deals
Bull · 25%C$82Margin variant
Bull+ · 5%C$99Sovereign sweep
Pipeline / BacklogUS$28B / 2.61BC$40B / C$3.69B
Q1'26 Book-to-Bill0.31×Conversion is the debate
Entry Valuation16–17×Forward EV / EBITDA range
Dilution / FD Shares16.6–19% / ~166M23M shares + greenshoe
Pro Forma Leverage at Close1.5–2.5×Net debt / adj. EBITDA
Consensus / House Margin~19.4% / 22%+Consensus base / unproven variant
Crowding10 Buy / 1 HoldZero sells · +72% YTD in package
FY30 Organic Outcome≈ 2× EBITDAUS$477M core free cash flow in house model
Dynamic chronology

Thesis arc

From the 2021 public relaunch to the FY30 outcome. Select an event to see why it matters, what confirms the thesis, and what breaks it.

Today · July 15, 2026
Selected event

✓ Why it matters

◎ What confirms

    △ What breaks

      The debate, made explicit

      Scoreboard & falsifiers

      The thesis works only if the US$28B pipeline converts before investors lose patience with shrinking backlog—and if conversion shows up in margin and cash, not just revenue.

      Five reasons MDA can double in 3–5 years

      01Bookings reloadHighestRCM + MELCO begin the turn; ESCP-P is the major unlock.
      02Montreal capacityHighUp to 400 satellites/year; the factory is built, not full.
      03Margin expansionHighCE holds ~19.4%; SatixFy, learning curve and SG&A leverage are the house bridge to the 22%+ variant.
      04Free Cash Flow InflectionHighCapex glides toward “one-fifty-ish” while EBITDA scales.
      05Recurring / Geointelligence MixMediumCLS + CHORUS can take Geointelligence toward ~30% of pro forma revenue.

      What Breaks It

      01Backlog Reload SlipsHighC$3.5B exit-FY26 without ESCP-P
      02Two-Deal Integration StumblesHighBCT/CLS closes, margins, cross-sell
      03Margin Bridge FailsMedium≤19.5% for two prints
      04Anchor Concentration Bites AgainMediumTelesat / Globalstar schedules
      05Balance Sheet or Dilution ResetsMediumLeverage outside 1.5–2.5× or new equity
      06CHORUS / Recurring Mix Is LateMediumLaunch, contracts and CLS pull-through
      Variant view

      Why the reset is mispriced

      The market charged the stock for dilution immediately, while assigning little credit to the strategic assets, the sovereign bookings calendar, or the FY27–30 earnings power.

      01

      Financing, not fundamentals

      The drawdown followed a 23M-share bought deal at US$35.60. The assets add capability; the equity makes dilution visible today.

      Test: stock stability after settlement
      02

      Pipeline doubled

      US$28B/C$40B is now defence-majority, with roughly US$7B down-selected or follow-on—closer to a bookings calendar than a TAM slide.

      Test: B2B back above 1×
      03

      Scarcity has operating leverage

      Montreal can support up to 400 satellites annually. Fixed capacity, SatixFy content and SG&A leverage create the margin bridge.

      Test: FY27 margin >20%
      04

      Deals fill missing pieces

      Blue Canyon opens cleared U.S. defence work; CLS brings downstream analytics, 14,000 customers and a channel for CHORUS.

      Test: on-time closes, margin retention
      05

      Earnings do most of the work

      The base case is driven primarily by EBITDA growth. It assumes a modest move from the roughly 16–17× entry multiple toward about 19×, not a heroic re-rating.

      Test: organic revenue and EBITDA track
      Listen before the meeting

      Embedded podcasts

      Three complementary briefings, led by the strongest underwriting episode: the deal logic, the vocabulary, and the durability question. Audio remains fully local and offline-capable.

      01

      Blue Canyon + CLS acquisition deep dive Featured · 30.8 min · Jul 12

      The best single audio route into the thesis: why two acquisitions in three weeks improve the platform—and why the proof burden still rises.

      02

      The complete MDA terminology briefing 24.1 min · Jul 14

      Every program, product, acronym, competitor and financial term needed for live Q&A.

      03

      Long-term sustainability & competitive lens

      The merchant-manufacturing moat, SpaceX gravity well, customer concentration and five-year durability test.

      One source of truth

      Pitch materials

      The July 13 folder is the official package. HTML is the editing source of truth; PDF is the print/send surface.

      Thesis evolution

      Prior team emails

      Five high-signal checkpoints from the team research trail. Every link opens a hosted HTML or PDF artifact directly—no Outlook sign-in required.

      Prepared for Conestoga Capital Advisors · internal investment research · 15 July 2026.Price and scenario framework anchored to the official 13 July 2026 pitch package. Forward estimates and targets are not guarantees.